title: Treatment of neovascular glaucoma after proton therapy for uveal melanomas with ranibizumab injection: preliminary results.
authors.affiliation: Department of Ophthalmology, Saint Roch Hospital, Nice-Sophia Antipolis University, Nice, France. ncaujolle@aol.com
authors.forename: Jean Pierre
authors.initials: JP
authors.lastname: Caujolle
authors.forename: Celia
authors.initials: C
authors.lastname: Maschi
authors.forename: Aurelien
authors.initials: A
authors.lastname: Freton
authors.forename: Gilles
authors.initials: G
authors.lastname: Pages
authors.forename: Pierre
authors.initials: P
authors.lastname: Gastaud
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D015355:Glaucoma, Neovascular / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007429:Intraocular Pressure; D058449:Intravitreal Injections; D008297:Male; D008545:Melanoma / Q000532:radiotherapy*; D008875:Middle Aged; D061766:Proton Therapy; D011522:Protons / Q000009:adverse effects*; D011882:Radiotherapy, High-Energy / Q000009:adverse effects*; D000069579:Ranibizumab; D012189:Retrospective Studies; D014604:Uveal Neoplasms / Q000532:radiotherapy*; D014792:Visual Acuity; D000098943:Uveal Melanoma
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D011522:Protons; D000069579:Ranibizumab